These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 27651745)
1. An Extremely Rare Intersection: Neurolymphomatosis in a Patient with Burkitt Lymphoma Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Oner AO; Okuyucu K; Alagoz E; Battal B; Arslan N World J Nucl Med; 2016 Sep; 15(3):209-11. PubMed ID: 27651745 [TBL] [Abstract][Full Text] [Related]
2. Neurolymphomatosis on F-18 FDG PET/CT and MRI Findings: A Case Report. Hong CM; Lee SW; Lee HJ; Song BI; Kim HW; Kang S; Jeong SY; Ahn BC; Lee J; Chae YS Nucl Med Mol Imaging; 2011 Mar; 45(1):76-8. PubMed ID: 24899982 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases. Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845 [TBL] [Abstract][Full Text] [Related]
5. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy]. Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis. Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562 [TBL] [Abstract][Full Text] [Related]
7. Neurolymphomatosis with Spinal Nerve Root Involvement Demonstrated on Arçay A; Bural GG; Şenol U Mol Imaging Radionucl Ther; 2022 Oct; 31(3):242-243. PubMed ID: 36268937 [TBL] [Abstract][Full Text] [Related]
8. Neurolymphomatosis as a late relapse of non-Hodgkin's lymphoma detected by 18F-FDG PET/CT: a case report. Kajáry K; Molnár Z; Mikó I; Barsi P; Lengyel Z; Szakáll S Rev Esp Med Nucl Imagen Mol; 2014; 33(1):39-42. PubMed ID: 23683830 [TBL] [Abstract][Full Text] [Related]
9. Neurolymphomatosis in follicular lymphoma: an autopsy case report. Ando T; Kamoshita S; Riku Y; Ito A; Ozawa Y; Miyamura K; Fujino M; Ito M; Goto Y; Mano K; Akagi A; Miyahara H; Katsuno M; Yoshida M; Iwasaki Y Neuropathology; 2022 Aug; 42(4):295-301. PubMed ID: 35607714 [TBL] [Abstract][Full Text] [Related]
10. Burkitt lymphoma and cavernous sinus syndrome with breast uptake on 18F-FDG-PET/CT: A case report. Reyneke F; Mokgoro N; Vorster M; Sathekge M Medicine (Baltimore); 2017 Nov; 96(46):e8687. PubMed ID: 29145302 [TBL] [Abstract][Full Text] [Related]
11. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes. Jeong J; Kim SW; Sung DH J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033 [TBL] [Abstract][Full Text] [Related]
12. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound. von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723 [TBL] [Abstract][Full Text] [Related]
14. [A case of neurolymphomatosis]. Gelezhe PB; Medvedeva AV Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8):150-153. PubMed ID: 36036417 [TBL] [Abstract][Full Text] [Related]
15. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
16. Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis. Salm LP; Van der Hiel B; Stokkel MP Nucl Med Commun; 2012 Sep; 33(9):907-16. PubMed ID: 22714006 [TBL] [Abstract][Full Text] [Related]
17. Neurolymphomatosis - Rare presentation in non-Hodgkin's lymphoma: The role of Fatima N; Zaman MU; Zaman A; Zaman SU World J Nucl Med; 2020; 19(2):159-161. PubMed ID: 32939208 [TBL] [Abstract][Full Text] [Related]
18. Neurolymphomatosis of the median nerve, optic nerve, L4 spinal nerve root and cauda equina in patients with B-cell malignancies: a case series. Alazawi S; Elomri H; Taha R; Bakr M; Abdelhamid MT; Szabados L; Yassin M; Sabah HE; Aboudi K; Ellahie A; Fadul A; Gameil A; Al Battah A; Fernyhough LJ J Med Case Rep; 2021 Mar; 15(1):133. PubMed ID: 33766128 [TBL] [Abstract][Full Text] [Related]
19. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes. Davidson T; Kedmi M; Avigdor A; Komisar O; Chikman B; Lidar M; Goshen E; Tzila Zwas S; Ben-Haim S Leuk Lymphoma; 2018 Feb; 59(2):348-356. PubMed ID: 28750592 [TBL] [Abstract][Full Text] [Related]
20. Secondary neurolymphomatosis of spinal nerve roots detected by ¹⁸F-FDG PET/CT: a case report and differential diagnosis of the case. Wang Y; Wang J; Jiang C; Peng Q; Wu M; Ma X Hell J Nucl Med; 2015; 18(3):261-3. PubMed ID: 26574697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]